Intravenous Infusion Pump Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 7.30 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Intravenous Infusion Pump Market Analysis
The Global Intravenous Infusion Pump Market size is expected to grow from USD 8.37 billion in 2023 to USD 11.90 billion by 2028, registering a CAGR of 7.30% during the forecast period (2023-2028).
COVID-19 had a significant impact on the intravenous infusion pump market. As COVID-19 spread around the globe initially, intensive care units (ICU) began to fill up with people who were critically ill from the virus. As COVID-19 patients began to flood hospital ICUs, infusion pump stocks quickly decreased. For instance, as per the article published by PubMed in February 2021, after the relocation of intravenous pumps from inside to outside the patient room, there was a considerable decrease in COVID-19 exposure based on the frequency of nurse entries. Furthermore, as per the article published by BMJ Journals in April 2021, as the intravenous tubing system was expanded outside the patient room, the complexity and cognitive demands of intravenous medication delivery increased, and nursing, pharmacy, and ordering professionals were conscious of the peculiarities of innovative arrangements, thereby improved the patient outcome. Thus, as per the factors mentioned above, COVID-19 had a profound impact on the market studied. However, as the pandemic has subsided, the studied market is expected to have normal growth during the forecast period of the study.
The increase in the geriatric population, rise in government initiatives, and growth in the adoption of portable infusion pumps are the key driving factors in the intravenous infusion pump market.
Infusion pumps enable automatic and precise administration of certain amounts of medication at predetermined periods. The market for intravenous infusion pumps is likely to grow owing to factors such as the increasing prevalence of chronic disease, rising healthcare expenditures, and increasing adoption of home healthcare settings. For instance, as per a May 2022 update from the CDC, 6 in 10 adults in the United States have a chronic disease, and 4 in 10 adults have two or more chronic diseases. Since patients with chronic disease are prone to nutrient shortages, a high prevalence of chronic disease is expected to increase the usage of IV infusion pumps. Furthermore, as per CDC 2022 update, chronic diseases are the biggest source of annual healthcare costs in the United States, equivalent to USD 4.1 trillion. Thus, the high burden of chronic diseases is expected to increase the usage of infusion pumps in hospitals.
Hence, as per the factors mentioned above, such as the increasing prevalence of chronic diseases and the rising geriatric population, the intravenous infusion pump market is anticipated to grow over the forecast period. However, the high costs and stringent regulatory approvals associated with IV infusion pumps restrain the market growth.
Intravenous Infusion Pump Market Trends
Volumetric Infusion Pump Segment is Expected to Witness a Healthy Growth Over the Forecast Period
Volumetric infusion pumps have a wide range of applications in disease management and parenteral nutrition, owing to which the market value for volumetric is the highest, compared to the markets for other pumps. The pumps' safety, accuracy, and simplicity are attributed to the high demand for these pumps.
The volumetric infusion pump segment holds a significant share of the intravenous infusion pump market and is anticipated to show a similar trend over the forecast period. The trend of adopting technologically advanced volumetric infusion pumps with capabilities such as electronic health record (EHR) integration, built-in safety systems, drug libraries, etc., is likely to drive market growth. For instance, according to an article published by the Journal of Patient Safety in August 2022, the use of intravenous (IV) medications via infusion pumps is a complex task inherently associated with patient safety risks, and an estimated 90% of hospitalized patients require the controlled administration of medications using the intravenous route. IV infusion pumps are prevalent in health care for controlled medication administration. While there are various infusion pumps, large-volume IV smart pumps are the most versatile and, thus, are the most commonly used type of infusion pump in United States acute care. Hence, such advantages of IV infusion pumps are likely to boost the market growth over the forecast period.
Furthermore, the high prevalence of chronic diseases is one of the major factors for adopting the IV infusion pump. For instance, as per the 2021 update from the CDC, the prevalence of doctor-diagnosed arthritis is expected to increase in the coming decades. By 2040, an estimated 78.4 million adults aged 18 years and older (25.9% of the projected adult population) are anticipated to have doctor-diagnosed arthritis. Moreover, as the socio-economic prospect of developing countries improves, more people are expected to be able to opt for the use of volumetric pumps in home healthcare, which, in turn, is likely to support the market growth over the forecast period.
Thus, the factors above, such as the rising incidence of chronic diseases and the increasing advantages of volumetric pumps, are expected to boost the market growth.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the intravenous infusion pump market due to an increase in the incidence of chronic diseases, the rising geriatric population, and favorable reimbursement policies in this region.
Furthermore, the rising prevalence of cancer is stimulating the region's growth. For instance, as per the Canada Cancer Society's stats for 2022 around 6,700 Canadians were diagnosed with leukemia in 2021, of which 4,000 were men and 2,700 were women in 2021. Also, as per the American Cancer Society's data for 2022, around 60,650 new cases of leukemia and 20,050 new cases of acute myeloid leukemia (AML) were reported in the United States in 2022. Of these, acute myeloid leukemia (AML) accounted for only about 1% of all cancers in the United States in 2022. Thus, the high incidence of blood cancer cases is leading to an increase in the usage of intravenous infusion pumps, thereby driving the market in the region.
Furthermore, government and private agency initiatives and recommendations regarding home care infusion settings promote market growth in the studied region. For instance, per the 2022 news published in National Home Infusion Association, several health systems, hospitals, and group purchasing organizations from all 50 states are urging Congress to address Medicare beneficiary access to home infusion treatments and approve legislation to enhance access to home-based care. Hence, such movements promote the home care setting to adopt IV infusion systems, thereby boosting market growth.
Hence, North America is expected to witness growth over the forecast period due to the factors mentioned above, such as the government and private agency initiatives and recommendations regarding home care infusion settings and the rising prevalence of chronic diseases.
Intravenous Infusion Pump Industry Overview
The intravenous infusion pump market is consolidated and consists of a few major players. In terms of market share, some of the companies which are currently dominating the market are B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson and Company, ICU Medical, Inc., IRadimed Corporation, Mindray, Moog Inc., Smiths Medical, Terumo Corporation, and Zyno Medical.
Intravenous Infusion Pump Market Leaders
B. Braun Melsungen AG
Becton, Dickinson and Company
IRadimed Corporation
Baxter International Inc.
ICU Medical, Inc.
*Disclaimer: Major Players sorted in no particular order
Intravenous Infusion Pump Market News
- August 2022: Baxter International Inc., a leader in innovative technology for medication delivery, received the United States Food and Drug Administration (FDA) 510(k) clearance for its new Novum IQ syringe infusion pump (SYR) with Dose IQ Safety Software, representing Baxter's latest developments for infusion therapy.
- March 2022: Shanghai MicroPort Lifesciences Co., Ltd. (MicroPort Lifesciences) received marketing approval from China's National Medical Products Administration (NMPA) for its independently developed new AutoEx Chemotherapy Infusion Pump (AutoEx).
Intravenous Infusion Pump Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the Prevalence of Chronic Diseases
4.2.2 Increasing Adoption in Home Healthcare Settings
4.2.3 Increasing Healthcare Investments in Developing Countries
4.3 Market Restraints
4.3.1 High Cost of Intravenous Infusion Pumps
4.3.2 Safety Issues and Stringent Regualtions
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Buyers/Consumers
4.4.2 Bargaining Power of Suppliers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Type
5.1.1 Volumetric Pumps
5.1.2 Syringe Pumps
5.1.3 Patient-Controlled Analgesia Pump
5.2 By Application
5.2.1 Analgesia/Pain Management
5.2.2 Oncology
5.2.3 Parenteral Nutrition
5.2.4 Other Applications
5.3 By End-User
5.3.1 Hospitals
5.3.2 Home Healthcare
5.3.3 Other End-Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun Melsungen AG
6.1.2 Baxter International Inc.
6.1.3 Becton, Dickinson and Company
6.1.4 ICU Medical, Inc.
6.1.5 IRadimed Corporation
6.1.6 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
6.1.7 Moog Inc.
6.1.8 Smiths Medical
6.1.9 Terumo Corporation
6.1.10 Zyno Medical
6.1.11 Advanced Instrumentations
6.1.12 Micrel Medical Devices SA
6.1.13 Plenum Tech Private Limited
6.1.14 Sino Medical-Device Technology Co., Ltd.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Intravenous Infusion Pump Industry Segmentation
As per the scope of the report, an intravenous infusion pump is a medical device that delivers fluids, such as nutrients and medications, into a patient's circulatory system through an intravenous route in controlled amounts. The Intravenous Infusion Pump Market is segmented By Type (Volumetric Pumps, Syringe Pumps, and Patient-Controlled Analgesia Pumps), Application (Analgesia/Pain Management, Oncology, Parenteral Nutrition, Other Applications), End-User (Hospitals, Home Healthcare, Other End-Users), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.
| By Type | |
| Volumetric Pumps | |
| Syringe Pumps | |
| Patient-Controlled Analgesia Pump |
| By Application | |
| Analgesia/Pain Management | |
| Oncology | |
| Parenteral Nutrition | |
| Other Applications |
| By End-User | |
| Hospitals | |
| Home Healthcare | |
| Other End-Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Intravenous Infusion Pump Market Research FAQs
What is the current Global Intravenous Infusion Pump Market size?
The Global Intravenous Infusion Pump Market is projected to register a CAGR of 7.30% during the forecast period (2024-2029)
Who are the key players in Global Intravenous Infusion Pump Market?
B. Braun Melsungen AG, Becton, Dickinson and Company, IRadimed Corporation, Baxter International Inc. and ICU Medical, Inc. are the major companies operating in the Global Intravenous Infusion Pump Market.
Which is the fastest growing region in Global Intravenous Infusion Pump Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Intravenous Infusion Pump Market?
In 2024, the North America accounts for the largest market share in Global Intravenous Infusion Pump Market.
What years does this Global Intravenous Infusion Pump Market cover?
The report covers the Global Intravenous Infusion Pump Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Intravenous Infusion Pump Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global Intravenous Infusion Pump Industry Report
Statistics for the 2024 Intravenous Infusion Pump market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Intravenous Infusion Pump analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
